Profile data is unavailable for this security.
About the company
Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer, liver diseases and obesity. The Company is still in the research and development stage. The Company's pipeline products include Afuresertib (LAE002), LAE001, LAE109, LAE111, LAE112, LAE113, LAE117, LAE118, LAE119, LAE102, LAE103, LAE104, LAE105, LAE106, LAE120, LAE123, and others. The Afuresertib is an adenosine triphosphate (ATP) competitive AKT inhibitor. The LAE001 is an androgen synthesis inhibitor that can inhibit CYP17A1 and CYP11B2 at the same time. The Company mainly conducts business in the Chinese, America, European, Korean, and other markets.
- Revenue in HKD (TTM)0.00
- Net income in HKD-325.23m
- Incorporated2016
- Employees92.00
- LocationLaekna IncZhongyi Ningbo Ecological Park, YuyaoNINGBO 200120ChinaCHN
- Websitehttps://www.laekna.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunho Biologics Inc | -100.00bn | -118.07m | 924.33m | -- | -- | 1.53 | -- | -- | -0.8765 | -0.8765 | -- | 3.85 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 14.77 | -4,626.67 | 0.0516 | -- | -- | -- | -155.25 | -- | -- | -- |
| Wuhan YZY Biopharma Co Ltd | 0.00 | -201.97m | 1.20bn | 114.00 | -- | 21.92 | -- | -- | -1.06 | -1.06 | 0.00 | 0.2815 | 0.00 | -- | -- | 0.00 | -83.99 | -- | -230.17 | -- | -- | -- | -- | -- | 1.21 | -44.35 | 0.7078 | -- | -- | -- | -1.50 | -- | -- | -- |
| Frontage Holdings Corp | 2.03bn | 47.53m | 1.24bn | 1.66k | 26.53 | 0.4735 | 3.67 | 0.613 | 0.023 | 0.023 | 0.9892 | 1.29 | 0.4701 | 56.23 | 4.18 | 1,151,748.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.19 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Hua Medicine | 119.89m | -289.85m | 1.26bn | 172.00 | -- | -- | -- | 10.48 | -0.2957 | -0.2957 | 0.1223 | -0.0372 | 0.0779 | 1.51 | 1.90 | 677,343.20 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| Mabpharm Ltd | 166.86m | -227.72m | 1.26bn | 347.00 | -- | 9.92 | -- | 7.54 | -0.0552 | -0.0552 | 0.0405 | 0.0307 | 0.164 | 0.1937 | 3.26 | 480,867.20 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -23.09 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 25.51m | -398.26m | 1.38bn | 298.00 | -- | 1.39 | -- | 54.14 | -0.513 | -0.513 | 0.0329 | 1.26 | 0.016 | -- | 2.41 | 84,767.09 | -24.89 | -45.76 | -28.66 | -49.30 | 3.45 | -- | -1,560.88 | -372.22 | -- | -- | 0.1794 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| Immunotech Biopharm Ltd | 0.00 | -340.29m | 1.38bn | 211.00 | -- | 15.51 | -- | -- | -0.6613 | -0.6613 | 0.00 | 0.1734 | 0.00 | -- | -- | 0.00 | -35.21 | -37.42 | -55.75 | -45.48 | -- | -- | -- | -- | 0.3638 | -2.44 | 0.6119 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
| TOT Biopharm International Co Ltd | 1.07bn | 9.87m | 1.55bn | 551.00 | 147.04 | 1.94 | 22.12 | 1.44 | 0.0136 | 0.0136 | 1.48 | 1.03 | 0.6899 | 2.44 | 6.35 | 1,943,674.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Laekna Inc | 0.00 | -325.23m | 1.75bn | 92.00 | -- | 2.35 | -- | -- | -0.9127 | -0.9127 | 0.00 | 1.91 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
| CARsgen Therapeutics Holdings Ltd | 6.98m | -764.71m | 1.76bn | 477.00 | -- | 1.08 | -- | 252.30 | -1.37 | -1.37 | 0.0125 | 2.86 | 0.0027 | -- | 0.302 | 13,521.54 | -29.27 | -- | -32.86 | -- | 25.50 | -- | -10,960.25 | -- | 9.44 | -- | 0.1246 | -- | -- | -- | 16.19 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 1.99bn | 145.00 | -- | 3.01 | -- | -- | -- | -- | -- | 1.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| CStone Pharmaceuticals | 502.41m | -156.61m | 1.99bn | 164.00 | -- | 3.87 | -- | 3.96 | -0.1229 | -0.1229 | 0.3941 | 0.4008 | 0.2861 | 1.33 | 2.50 | 2,184,394.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| Abbisko Cayman Ltd | 547.24m | -17.83m | 2.12bn | 275.00 | -- | 0.9214 | 582.94 | 3.88 | -0.0302 | -0.0302 | 0.8426 | 3.35 | 0.2159 | -- | -- | 2,121,104.00 | -0.7034 | -- | -0.733 | -- | 100.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
| Alphamab Oncology | 281.58m | -237.30m | 2.44bn | 429.00 | -- | 1.36 | -- | 8.66 | -0.2465 | -0.2465 | 0.2925 | 1.86 | 0.1145 | 0.8256 | 13.94 | 647,316.60 | -9.65 | -18.72 | -11.16 | -21.94 | 79.33 | -- | -84.27 | -415.55 | 4.42 | -- | 0.167 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 881.03m | -268.32m | 2.48bn | 1.04k | -- | 3.05 | -- | 2.82 | -0.6737 | -0.6737 | 2.21 | 2.04 | 0.3109 | 23.64 | 5.35 | 826,478.40 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -3.22 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to Laekna Inc's reporting currency: Hong Kong Dollar HKD
1.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 1.41m | 0.36% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 511.50k | 0.13% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 477.07k | 0.12% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 461.50k | 0.12% |
| Great Wall Fund Management Co., Ltd.as of 31 Dec 2023 | 443.00k | 0.11% |
| Ping An Fund Management Co., Ltd.as of 31 Dec 2023 | 352.00k | 0.09% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 346.50k | 0.09% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 219.00k | 0.06% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 187.50k | 0.05% |
| Franklin Templeton Sealand Fund Management Co., Ltd.as of 31 Dec 2023 | 68.50k | 0.02% |
More ▼
Data from 31 Dec 2023 - 12 Sep 2024Source: FactSet Research Systems Inc.
